Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aaron Mendelsohn Insider Profile
4 Followers
Aaron Mendelsohn, Director at Second Sight Medical Products, holds 133.81K shares in Second Sight Medical Products (Ticker: EYES).
Aaron Mendelsohn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Aaron Mendelsohn's holdings
Insider Roles
Director
Roles that Aaron Mendelsohn holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 21, 2014 - Nov 21, 2015
Return:-77.40%
The most profitable trade made by Aaron Mendelsohn
Aaron Mendelsohn's Trading History
List of latest transactions for each holding click on a transaction to see Aaron Mendelsohn's performance on stock
You May Also Like
Aaron Mendelsohn insider profile FAQ
What is the percentage of profitable transactions made by Aaron Mendelsohn?
The percentage of profitable transactions made by Aaron Mendelsohn is ―.
What is the average return per transaction made by Aaron Mendelsohn?
The average return per transaction made by Aaron Mendelsohn is ―.
What stocks does Aaron Mendelsohn hold?
Aaron Mendelsohn holds: EYES stocks.
What was Aaron Mendelsohn’s latest transaction?
Aaron Mendelsohn latest transaction was an Uninformative Buy of ―.
What was Aaron Mendelsohn's most profitable transaction?
Aaron Mendelsohn’s most profitable transaction was an Informative Buy of EYES stock on November 21, 2014. The return on the trade was -77.40%.
What is Aaron Mendelsohn's role in Second Sight Medical Products?
Aaron Mendelsohn's role in Second Sight Medical Products is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.